SNDX Company Profile and Key Details

Q: Who are the executives of SNDX?

Sharon KlahreVice President of Investor Relations & CommunicationsDr. Peter Ordentlich B.Sc., Ph.D.Co-Founder & Chief Scientific OfficerDr. Briggs W. Morrison M.D.Pres, Head of R&D and DirectorDr. Ronald M. Evans Ph.D.Co-Founder, Advisor and Chair of Scientific Advisory BoardDr. Michael Downes Ph.D.Co-FounderDr. Briggs W. Morrison M.D., Ph.D.Pres, Head of R&D and DirectorMr. Michael A. Metzger M.B.A.Chief Executive Officer & DirectorDr. Anjali Ganguli Ph.D.Chief Bus. OfficerMr. Keith Alan Goldan CPAChief Financial Officer, Treasurer & Chief Accounting OfficerMr. Steve M. SabusChief Commercial OfficerMr. Luke J. AlbrechtSenior Vice President, Gen. Counsel & Sec.Dr. Catherine Madigan M.D.Chief Medical OfficerMr. Alexander NolteInterim Chief Financial Officer, Principal Accounting Officer & Treasurer

NASDAQ : SNDX

Syndax Pharmaceuticals

$21.40

-0.74-3.34%

At Close 4:00 PM

55.95

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Syndax Pharmaceuticals, Inc. (SNDX) stock declined over -3.34%, trading at $21.40 on NASDAQ, down from the previous close of $22.14. The stock opened at $21.96, fluctuating between $21.00 and $22.38 in the recent session.

Stock Snapshot

22.14

Prev. Close

1.86B

Market Cap

Day Low

-5.94

P/E Ratio

-3.6

EPS (TTM)

-2.21

Cash Flow per Share

21.96

Open

86.91M

Number of Shares

22.38

Day High

94.89%

Free Float in %

7.64

Book Value

1.14M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 03, 2026	21.96	22.39	21.00	21.40	1.18M
Mar 02, 2026	21.61	22.68	21.00	22.14	1.68M
Feb 27, 2026	20.00	21.76	19.21	21.71	2.25M
Feb 26, 2026	20.75	20.88	20.25	20.67	1.33M
Feb 25, 2026	20.63	20.80	20.30	20.75	1.23M
Feb 24, 2026	19.97	20.64	19.78	20.53	655.46K
Feb 23, 2026	19.84	20.40	19.45	19.90	797.15K
Feb 20, 2026	20.64	20.71	19.68	19.69	1.7M
Feb 19, 2026	20.27	20.90	20.08	20.63	907.34K
Feb 18, 2026	20.21	20.75	20.02	20.25	994.26K
Feb 17, 2026	20.40	20.61	20.07	20.34	588.26K
Feb 13, 2026	21.04	21.39	20.43	20.48	1.42M
Feb 12, 2026	21.83	21.83	20.95	21.14	952.28K
Feb 11, 2026	21.36	21.86	20.50	21.71	1.15M
Feb 10, 2026	21.09	22.00	21.01	21.32	960.97K
Feb 09, 2026	20.92	21.35	20.75	21.19	1.09M
Feb 06, 2026	20.48	21.18	20.25	21.01	1.46M
Feb 05, 2026	20.49	21.26	20.00	20.15	1.67M
Feb 04, 2026	21.31	21.40	20.18	20.43	798.44K
Feb 03, 2026	21.53	21.89	20.70	21.25	836.16K

Contact Details

New York City, MA 02451

United States

https://www.syndax.com 781 419 1400

About Company

Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin 1 mutant acute myeloid leukemia (NPM1c AML); and SNDX-6352 or axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1, or CSF-1 receptor for the treatment of patients with chronic graft versus host disease (cGVHD). The company is also developing Entinostat. It also has collaborative research and development agreement with National Cancer Institute; a clinical trial agreement with Eastern Cooperative Oncology Group; and a license agreement with Kyowa Hakko Kirin Co., Ltd. Syndax Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Waltham, Massachusetts.Massachusetts.

Stock Peers

REGN

-24.1-3.05%

Regeneron Pharmaceuticals, Inc.$766.66 ARGX

-8.04-1.06%

argenx SE$748.72 UTHR

-15.17-2.95%

United Therapeutics Corporation$498.65 VRTX

-11.76-2.42%

Vertex Pharmaceuticals Incorporated$474.27 MDGL

-9.77-2.24%

Madrigal Pharmaceuticals, Inc.$425.85 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 ALNY

-6.42-1.97%

Alnylam Pharmaceuticals, Inc.$318.65 PRAX

-12.37-3.74%

Praxis Precision Medicines, Inc.$318.22 KRYS

4.99+1.93%

Krystal Biotech, Inc.$263.80 ASND

-2.87-1.19%

Ascendis Pharma A/S$239.22

Frequently Asked Questions

What is the current Syndax Pharmaceuticals, Inc. (SNDX) stock price?

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) stock price is $21.40 in the last trading session. During the trading session, SNDX stock reached the peak price of $22.38 while $21.00 was the lowest point it dropped to. The percentage change in SNDX stock occurred in the recent session was -3.34% while the dollar amount for the price change in SNDX stock was - $0.74.

SNDX's industry and sector of operation?

The NASDAQ listed SNDX is part of Biotechnology industry that operates in the broader Healthcare sector. Syndax Pharmaceuticals, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of SNDX?

Sharon Klahre
Vice President of Investor Relations & Communications
Dr. Peter Ordentlich B.Sc., Ph.D.
Co-Founder & Chief Scientific Officer
Dr. Briggs W. Morrison M.D.
Pres, Head of R&D and Director
Dr. Ronald M. Evans Ph.D.
Co-Founder, Advisor and Chair of Scientific Advisory Board
Dr. Michael Downes Ph.D.
Co-Founder
Dr. Briggs W. Morrison M.D., Ph.D.
Pres, Head of R&D and Director
Mr. Michael A. Metzger M.B.A.
Chief Executive Officer & Director
Dr. Anjali Ganguli Ph.D.
Chief Bus. Officer
Mr. Keith Alan Goldan CPA
Chief Financial Officer, Treasurer & Chief Accounting Officer
Mr. Steve M. Sabus
Chief Commercial Officer
Mr. Luke J. Albrecht
Senior Vice President, Gen. Counsel & Sec.
Dr. Catherine Madigan M.D.
Chief Medical Officer
Mr. Alexander Nolte
Interim Chief Financial Officer, Principal Accounting Officer & Treasurer

How SNDX did perform over past 52-week?

SNDX's closing price is 149.42% higher than its 52-week low of $8.58 where as its distance from 52-week high of $22.73 is -5.85%.

How many employees does SNDX have?

Number of SNDX employees currently stands at 270.

Link for SNDX official website?

Official Website of SNDX is: https://www.syndax.com

How do I contact SNDX?

SNDX could be contacted at phone 781 419 1400 and can also be accessed through its website. SNDX operates from 35 Gatehouse Drive, New York City, MA 02451, United States.

How many shares of SNDX are traded daily?

SNDX stock volume for the day was 1.14M shares. The average number of SNDX shares traded daily for last 3 months was 1.36M.

What is the market cap of SNDX currently?

The market value of SNDX currently stands at $1.86B with its latest stock price at $21.40 and 86.91M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	270
Beta	0.46
Sales or Revenue	$0.00
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	270
Beta	0.46
Sales or Revenue	$0.00
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

SNDX Company Profile and Key Details

Syndax Pharmaceuticals

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Financial & Profitability Overview

Quarterly Financial Highlights

Shareholding & Insider Activity

Earnings & Analyst Outlook

Dividend & Fair Value

Company Overview

Valuation Metrics

Price Forecast & Outlook

Key Takeaways